You have 9 free searches left this month | for more free features.

Eukaryotic initiation factor 4E

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer

Recruiting
  • Colo-rectal Cancer
  • serum HOTTIP ,EIF4EBP1 and serum SNP HOTTIP rs1859168
  • Assiut, Egypt
    Assiut University
Aug 18, 2022

Traumatic Hemorrhage, Coagulopathy, Massive Hemorrhage Trial in Hamitlon, London, Toronto (Fibrinogen + PCC, Frozen Plasma)

Recruiting
  • Traumatic Hemorrhage
  • +2 more
  • Fibrinogen + PCC
  • Frozen Plasma
  • Vancouver, British Columbia, Canada
  • +5 more
Dec 1, 2022

Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Phoenix, Arizona
  • +36 more
Jan 27, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New Haven, Connecticut
  • +4 more
Jan 27, 2023

Motor Neuron Disease Trial in Sydney, Melbourne (Monepantel)

Recruiting
  • Motor Neuron Disease
  • Sydney, New South Wales, Australia
  • +1 more
Jun 28, 2022

Kidney Tumors Trial in Taoyuan (multiparametric and fat-detection magnetic resonance imaging (MRI))

Active, not recruiting
  • Kidney Neoplasms
  • multiparametric and fat-detection magnetic resonance imaging (MRI)
  • Taoyuan, Taiwan
    Li-Jen Wang
Nov 9, 2023

Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Capivasertib, Matched Capivasertib Placebo,

Recruiting
  • Locally Advanced (Inoperable) or Metastatic Breast Cancer
  • Los Angeles, California
  • +76 more
Nov 25, 2022

Hemophilia Trial in Worldwide (Fitusiran)

Completed
  • Hemophilia
  • Little Rock, Arkansas
  • +43 more
May 11, 2022

IGF1 Deficiency Trial in Worldwide (Increlex®)

Recruiting
  • IGF1 Deficiency
  • Miami, Florida
  • +50 more
Dec 29, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aldesleukin
  • +9 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Borderline Resectable Pancreatic Carcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Resectable Pancreatic

Recruiting
  • Borderline Resectable Pancreatic Carcinoma
  • +8 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 25, 2022

Cholangiocarcinoma Trial in China, Japan (E7090)

Active, not recruiting
  • Cholangiocarcinoma
  • Bengbu, Anhui, China
  • +55 more
Jan 24, 2023

Exercise Training Trial in Omaha (Muscle Cooling, Resistance Exercise)

Not yet recruiting
  • Exercise Training
  • Muscle Cooling
  • Resistance Exercise
  • Omaha, Nebraska
    University of Nebraska at Omaha
May 16, 2022

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Acute Myelogenous Leukemia Trial in Rochester (Decitabine)

Completed
  • Acute Myelogenous Leukemia
  • Rochester, New York
    University of Rochester
Jul 1, 2022

IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biological Substance; Adverse Effect
  • Azithromycin Pill
  • Placebo
  • Haifa, Israel
    Rambam Health Care Campus
Oct 25, 2022

Cardiovascular Diseases, Obesity, Visceral, Liver Fat Trial in Québec (High-volume road cycling)

Completed
  • Cardiovascular Diseases
  • +4 more
  • High-volume road cycling
  • Québec, Canada
    Institut universitaire de cardiologie et de pneumologie de Québe
May 30, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

Completed
  • Human Papillomavirus (HPV)-Related Malignancies
  • Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
  • Basking Ridge, New Jersey
  • +5 more
Dec 14, 2022

Hereditary Angioedema Trial in Worldwide (CSL312, Placebo)

Completed
  • Hereditary Angioedema
  • CSL312
  • Placebo
  • Birmingham, Alabama
  • +27 more
Aug 2, 2022

Hemophilia A, Hemophilia B Trial in Worldwide (fitusiran, factor concentrates)

Completed
  • Hemophilia A
  • Hemophilia B
  • Little Rock, Arkansas
  • +63 more
Mar 15, 2022

Hemophilia A Trial in Worldwide (Recombinant Protein-Free Factor VIII (rAHF-PFM))

Completed
  • Hemophilia A
  • Recombinant Protein-Free Factor VIII (rAHF-PFM)
  • Los Angeles, California
  • +35 more
Apr 28, 2021

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)

Recruiting
  • Hidradenitis Suppurativa
  • Lutikizumab
  • Placebo
  • Phoenix, Arizona
  • +54 more
Jan 26, 2023